| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8229119 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 7 Pages |
Abstract
In the present series, no BRAF mutation was detected. The presence of KRAS mutations and loss of PTEN expression were not associated with impaired response to cetuximab-based chemoradiotherapy and 3-year DFS.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Philipp M.D., Philipp M.D., Karoline M.D., Juliana M.D., Beatrice Bohn, Benjamin M.D., Georg M.D., Peter M.D., Stefan M.D., Frederik M.D., Andreas M.D., Ralf-Dieter M.D.,